Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

ClinicalTrials.gov ID: NCT04635891

Public ClinicalTrials.gov record NCT04635891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary goal of this proposal is to collect motor and functional outcomes specific to FSHD over time. By collecting measures specific to FSHD, this will help ensure the best level of clinical care is being provided. Also, the hope is to speed up drug development by gaining a better understanding of how having FSHD impacts motor function and other health outcomes (i.e. breathing, wheelchair use, etc.) and how big a change in motor function would be clinically meaningful to those with FSHD. Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) will have approximately 450 FSHD participants followed for a minimum of 3 years. A subset of MOVE FSHD participants, approximately 200, will participate in the MOVE+ sub-study which includes whole body MRI and reachable workspace, as well as optional muscle biopsy and wearable device (US participants only).

Study identification

NCT ID
NCT04635891
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Enrollment
450 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2020
Primary completion
Nov 30, 2027
Completion
Dec 31, 2027
Last update posted
May 6, 2026

2020 – 2028

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
David Geffen School of Medicine at UCLA Los Angeles California 90095 Recruiting
Neuromuscular Disorders Program at Stanford University School of Medicine Stanford California 94306 Recruiting
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 Recruiting
Univeristy of Florida Gainesville Gainesville Florida 32608 Recruiting
University of Iowa Iowa City Iowa 52242 Recruiting
Univeristy of Kansas Medical Center Kansas City Kansas 66160 Recruiting
Kennedy Krieger Institute Baltimore Maryland 21205 Recruiting
University of Rochester Medical Center Rochester New York 14642 Recruiting
Duke University - Lenox Baker Children's Hospital Durham North Carolina 27705 Recruiting
The Ohio State University Medical Center Columbus Ohio 43221 Recruiting
Austin Neuromuscular Center Austin Texas 78759 Recruiting
Univeristy of Texas Southwestern Medical Center Dallas Texas 75390 Recruiting
University of Texas Health San Antonio San Antonio Texas 78229 Not yet recruiting
University of Utah Salt Lake City Utah 84132 Recruiting
Virginia Commonwealth University Richmond Virginia 23219 Recruiting
University of Washington Medical Center Seattle Washington 98195 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04635891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04635891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →